Are calcineurin inhibitors safer than mTOR inhibitors?

被引：0

作者：

Heidi Yeh

James F. Markmann

机构：

[1] Massachusetts General Hospital,Division of Transplant Surgery

来源：

Nature Reviews Nephrology | 2013年 / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Isakova et al. report that kidney transplant recipients on mammalian target of rapamycin (mTOR) inhibitors do not have a lower risk of allograft failure but do have a higher risk of death than those on calcineurin inhibitors. Careful consideration is, therefore, required before converting to mTOR inhibitors to preserve renal function.

引用

页码：11 / 13

页数：2

共 50 条

[1] TRANSPLANTATION Are calcineurin inhibitors safer than mTOR inhibitors?
Yeh, Heidi
Markmann, James F.
NATURE REVIEWS NEPHROLOGY, 2013, 9 (01) : 11 - 13
[2] Replacing calcineurin inhibitors with mTOR inhibitors in children
Sindhi, R
Seward, J
Mazariegos, G
Soltys, K
Seward, L
Smith, A
Kosmach, B
Venkataramanan, R
PEDIATRIC TRANSPLANTATION, 2005, 9 (03) : 391 - 397
[3] Conversion from calcineurin inhibitors to mTOR inhibitors
Bodziak, Kenneth A.
Hrick, Donald E.
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (04) : 351 - 356
[4] CALCINEURIN INHIBITORS ELIMINATION: WHICH MTOR TO BE CHOSEN?
Gheith, Osama
Alotaibi, Torki
Abdulhalim, Medhat
Nampoory, Naryanam
Said, Tarek
Nair, Prasad
TRANSPLANT INTERNATIONAL, 2017, 30 : 473 - 473
[5] Late withdrawal of calcineurin inhibitors and switch to mTOR inhibitors - beneficial or too late?
Hoyer, Peter F.
PEDIATRIC TRANSPLANTATION, 2011, 15 (08) : 767 - 769
[6] mTor but not calcineurin inhibitors affect endothelial growth and function
Lehle, K
Schreml, S
Rupprecht, L
Birnbaum, DE
Preuner, JG
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 712 - 712
[7] Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience
Oguz, Ebru Gok
Yildirim, Tolga
Merhametsiz, Ozgur
Yayar, Ozlem
Gursoy, Guner Karaveli
Spulat, Ayhan Ha
Ercan, Zafer
Akoglu, Hadim
Akdag, Seyit Ibrahim
Ayli, Deniz
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2014, 23 (03): : 229 - 233
[8] Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors
Habib, Nancy
Salaro, Cristina
Al-Ghaithi, Khalid
Phelps, Robert G.
Saggar, Sarika
Cohen, Steven R.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (01) : 91 - 94
[9] The limitations of calcineurin and mTOR inhibitors: New directions for immunosuppressive strategies
Kahan, BD
TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 130 - 133
[10] Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation
Asante-Korang, Alfred
Carapellucci, Jennifer
Krasnopero, Diane
Doyle, Abigail
Brown, Brian
Amankwah, Ernest
CLINICAL TRANSPLANTATION, 2017, 31 (10)

← 1 2 3 4 5 →